NCT02399371 2025-06-11
Pembrolizumab in Treating Patients With Malignant Mesothelioma
University of Chicago
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT01713972 2019-03-01
Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT01705106 2018-05-30
Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies
University of Chicago
Phase 1 Terminated
NCT00731276 2017-03-31
Irinotecan in Treating Asian Patients With Solid Tumors
National Cancer Centre, Singapore
Phase 1 Completed